This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biokine Therapeutics Ltd.. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2013
Title: Hirokazu Tamamura: Innovator in Therapeutic Drug Development
Introduction
Hirokazu Tamamura is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of therapeutic drugs, particularly in the development of treatments for cancer and chronic rheumatoid arthritis. With a total of 3 patents to his name, Tamamura's work is recognized for its innovative approach to addressing critical health issues.
Latest Patents
Tamamura's latest patents include groundbreaking work on CXCR4 antagonists. His inventions describe therapeutic drugs that contain peptides exhibiting CXCR4 antagonism, along with their amides, esters, or salts. These compounds have shown promise in treating cancer and chronic rheumatoid arthritis. The patents highlight the therapeutic effects of these peptides, emphasizing their potential in medical applications.
Career Highlights
Hirokazu Tamamura is associated with Biokine Therapeutics Ltd., where he continues to advance his research and development efforts. His career is marked by a commitment to innovation in the pharmaceutical industry, focusing on creating effective treatments for serious health conditions.
Collaborations
Tamamura collaborates with notable colleagues, including Akira Hori and Nobutaka Fujii. Their combined expertise contributes to the success of their projects and enhances the impact of their research in the field.
Conclusion
Hirokazu Tamamura's contributions to therapeutic drug development, particularly through his patents on CXCR4 antagonists, underscore his role as a leading inventor in the medical field. His work continues to pave the way for innovative treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile